Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2012 (2012), Article ID 720185, 9 pages
http://dx.doi.org/10.1155/2012/720185
Review Article

Melatonin: A Novel Indolamine in Oral Health and Disease

Department of Periodontics, Narayana Dental College & Hospital, Nellore, Andhra Pradesh, Nellore 524002, India

Received 2 January 2012; Accepted 31 May 2012

Academic Editor: Ali I. Abdalla

Copyright © 2012 V. K. Chava and K. Sirisha. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kalsbeek and R. M. Buijs, “Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting,” Cell and Tissue Research, vol. 309, no. 1, pp. 109–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Claustrat, J. Brun, and G. Chazot, “The basic physiology and pathophysiology of melatonin,” Sleep Medicine Reviews, vol. 9, no. 1, pp. 11–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Lerner, J. D. Case, Y. Takahashi, T. H. Lee, and W. Mori, “Isolation of melatonin, the pineal gland factor that lightens melanocytes,” Journal of the American Chemical Society, vol. 80, no. 10, p. 2587, 1958. View at Google Scholar · View at Scopus
  4. C. P. Mc Cord and F. P. Allen, “Evidence associating pineal gland function with alterations in pigmentation,” Journal of Experimental Zoology, vol. 23, no. 1, pp. 207–224, 1917. View at Publisher · View at Google Scholar
  5. R. J. Reiter, S. D. Paredes, L. C. Manchester, and D. X. Tan, “Reducing oxidative/nitrosative stress newly discovered gene for melatonin,” Critical Reviews in Biochemistry and Molecular Biology, vol. 44, no. 4, pp. 175–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Cutando, G. Gómez-Moreno, C. Arana, D. Acuña-Castroviejo, and R. J. Reiter, “Melatonin: potential functions in the oral cavity,” Journal of Periodontology, vol. 78, no. 6, pp. 1094–1102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Sugden and D. C. Klein, “A cholera toxin substrate regulates cyclic GMP content of rat pinealocytes,” Journal of Biological Chemistry, vol. 262, no. 16, pp. 7447–7450, 1987. View at Google Scholar · View at Scopus
  8. R. J. Reiter, “Pineal melatonin: cell biology of its synthesis and of its physiological interactions,” Endocrine Reviews, vol. 12, no. 2, pp. 151–180, 1991. View at Google Scholar · View at Scopus
  9. R. Y. Moore, “Neural control of the pineal gland,” Behavioural Brain Research, vol. 73, no. 1-2, pp. 125–130, 1996. View at Google Scholar
  10. R. J. Reiter, “Melatonin: clinical relevance,” Best Practice and Research, vol. 17, no. 2, pp. 273–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Sugden, H. Pickering, M. T. Teh, and P. J. Garratt, “Melatonin receptor pharmacology: toward subtype specificity,” Biology of the Cell, vol. 89, no. 8, pp. 531–537, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Guerrero, D. Pozo, S. Garcia-Maurino, C. Osuna, P. Molinero, and J. R. Calvo, “Involvement of nuclear receptors in the enhanced IL-2 production by melatonin in Jurkat cells,” Annals of the New York Academy of Sciences, vol. 917, pp. 397–403, 2000. View at Google Scholar
  13. S. M. Reppert, “Melatonin receptors: molecular biology of a new family of G protein-coupled receptors,” Journal of Biological Rhythms, vol. 12, no. 6, pp. 528–531, 1997. View at Google Scholar · View at Scopus
  14. M. L. Dubocovich, D. P. Cardinali, B. Guardiola-Lemailre et al., “Melatonin receptors,” in IUPHAR Compendium of Receptor Characterization and Classification, pp. 187–193, IUPHAR Media, London, UK, 1998. View at Google Scholar
  15. S. M. Reppert, D. R. Weaver, and C. Liu, “Nature's knockout: the Mel1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters,” Molecular Endocrinology, vol. 10, no. 11, pp. 1478–1487, 1996. View at Google Scholar · View at Scopus
  16. M. L. Dubocovich, M. A. Rivera-Bermudez, M. J. Gerdin, and M. I. Masana, “Molecular pharmacology, regulation and function of mammalian melatonin receptors,” Frontiers in Bioscience, vol. 8, pp. 1093–1108, 2003. View at Google Scholar · View at Scopus
  17. C. Von Gall, J. H. Stehle, and D. R. Weaver, “Mammalian melatonin receptors: molecular biology and signal transduction,” Cell and Tissue Research, vol. 309, no. 1, pp. 151–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Buijs and A. Kalsbeek, “Hypothalamic integration of central and peripheral clocks,” Nature Reviews Neuroscience, vol. 2, no. 7, pp. 521–526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. C. Klein and R. Y. Moore, “Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: control by the retinohypothalamic tract and the suprachiasmatic nucleus,” Brain Research, vol. 174, no. 2, pp. 245–262, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Simonneaux and C. Ribelayga, “Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters,” Pharmacological Reviews, vol. 55, no. 2, pp. 325–395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. R. J. Reiter, “Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals,” Journal of neural transmission. Supplementum, vol. 21, pp. 35–54, 1986. View at Google Scholar · View at Scopus
  22. M. Czesnikiewicz-Guzik, S. J. Konturek, B. Loster, G. Wisniewska, and S. Majewski, “Melatonin and its role in oxidative stress related diseases of oral cavity,” Journal of Physiology and Pharmacology, vol. 58, no. 3, pp. 5–19, 2007. View at Google Scholar · View at Scopus
  23. S. Romsing, F. Bokman, and Y. Bergovist, “Determination of melatonin in saliva using automated solid phase extraction, high performance liquid chromatography and florescence detection,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 66, no. 1, pp. 181–190, 2006. View at Google Scholar
  24. M. L. Laakso, T. Porkka-Heiskanen, A. Alila, D. Stenberg, and G. Johansson, “Correlation between salivary and serum melatonin: dependence on serum melatonin levels,” Journal of Pineal Research, vol. 9, no. 1, pp. 39–50, 1990. View at Google Scholar · View at Scopus
  25. A. Cutando, G. Gómez-Moreno, J. Villalba, M. J. Ferrera, G. Escames, and D. Acuña-Castroviejo, “Relationship between salivary melatonin levels and periodontal status in diabetic patients,” Journal of Pineal Research, vol. 35, no. 4, pp. 239–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. J. Burgess and L. F. Fogg, “Individual differences in the amount and timing of salivary melatonin secretion,” PLoS ONE, vol. 3, no. 8, Article ID e3055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Reiter, “The mammalian pineal gland: structure and function,” American Journal of Anatomy, vol. 162, no. 4, pp. 287–313, 1981. View at Google Scholar · View at Scopus
  28. O. Vakkuri, J. Leppaluoto, and A. Kauppila, “Oral administration and distribution of melatonin in human serum, saliva and urine,” Life Sciences, vol. 37, no. 5, pp. 489–495, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Vakkuri, “Diurnal rhythm of melatonin in human saliva,” Acta Physiologica Scandinavica, vol. 124, no. 3, pp. 409–412, 1985. View at Google Scholar · View at Scopus
  30. R. Nowak, I. C. McMillen, J. Redman, and R. V. Short, “The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity,” Clinical Endocrinology, vol. 27, no. 4, pp. 445–452, 1987. View at Google Scholar · View at Scopus
  31. G. Gómez-Moreno, J. Guardia, M. J. Ferrera, A. Cutando, and R. J. Reiter, “Melatonin in diseases of the oral cavity,” Oral Diseases, vol. 16, no. 3, pp. 242–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Chaiyarit, N. Ma, Y. Hiraku et al., “Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis,” Cancer Science, vol. 96, no. 9, pp. 553–559, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Taubman, P. Valverde, X. Han, and T. Kawai, “Immune response: they key to bone resorption in periodontal disease,” Journal of Periodontology, vol. 76, no. 11, pp. 2033–2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Cutando and F. J. Silvestre, “Melatonin: implications at the oral level,” Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie, vol. 38, no. 3-4, pp. 81–86, 1995. View at Google Scholar · View at Scopus
  35. S. Kumasaka, M. Shimozuma, T. Kawamoto et al., “Possible involvement of melatonin in tooth development: expression of melatonin 1a receptor in human and mouse tooth germs,” Histochemistry and Cell Biology, vol. 133, no. 5, pp. 577–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. C. Mechin and C. Toury, “Action of cariogenic diet on fixation and retention of skeleton and teeth strontium in rats,” Rev Mens Suisse Odontostomatol, vol. 20, no. 1, pp. 55–59, 1973. View at Google Scholar · View at Scopus
  37. A. Cutando, P. Galindo, G. Gómez-Moreno et al., “Relationship between salivary melatonin and severity of periodontal disease,” Journal of Periodontology, vol. 77, no. 9, pp. 1533–1538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Cutando, C. Arana, G. Gómez-Moreno et al., “Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress,” Journal of Periodontology, vol. 78, no. 3, pp. 576–583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Cutando, G. Gomez-Moreno, C. Arana, G. Escames, and D. Acuña-Castroviejo, “Melatonin reduces oxidative stress because of tooth removal,” Journal of Pineal Research, vol. 42, no. 4, pp. 419–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. I. F. Tresguerres, C. Clemente, L. Blanco et al., “Effects of local melatonin application on implant osseointegration,” Clinical Implant Dentistry and Related Research, vol. 14, no. 3, pp. 395–399, 2012. View at Publisher · View at Google Scholar
  41. J. L. Calvo-Guirado, G. Gómez-Moreno, A. Barone et al., “Melatonin plus porcine bone on discrete calcium deposit implant surface stimulates osteointegration in dental implants,” Journal of Pineal Research, vol. 47, no. 2, pp. 164–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. L. Calvo-Guirado, M. P. Ramírez-Fernández, G. Gómez-Moreno et al., “Melatonin stimulates the growth of new bone around implants in the tibia of rabbits,” Journal of Pineal Research, vol. 49, no. 4, pp. 356–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Cutando, G. Gómez-Moreno, C. Arana et al., “Melatonin stimulates osteointegration of dental implants,” Journal of Pineal Research, vol. 45, no. 2, pp. 174–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Nakade, H. Koyama, H. Ariji, A. Yajima, and T. Kaku, “Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro,” Journal of Pineal Research, vol. 27, no. 2, pp. 106–110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Koyama, O. Nakade, Y. Takada, T. Kaku, and K. H. W. Lau, “Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation,” Journal of Bone and Mineral Research, vol. 17, no. 7, pp. 1219–1229, 2002. View at Google Scholar · View at Scopus
  46. P. A. Simon and Z. Watson, “Bio mimetic dental implants- new ways to enhance osteointegration,” Journal of the Canadian Dental Association, vol. 68, no. 5, pp. 286–288, 2002. View at Google Scholar
  47. J. Blasiak, J. Kasznicki, J. Drzewoski, E. Pawlowska, J. Szczepanska, and R. J. Reiter, “Perspectives on the use of melatonin to reduce cytotoxic and genotoxic effects of methacrylate-based dental materials,” Journal of Pineal Research, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Cevik-Aras, T. Godoy, and J. Ekstrom, “Melatonin-induced protein synthesis in the rat parotid gland,” Journal of Physiology and Pharmacology, vol. 62, no. 1, pp. 95–99, 2011. View at Google Scholar · View at Scopus
  49. M. Shimozuma, R. Tokuyama, S. Tatehara et al., “Expression and cellular localizaion of melatonin-synthesizing enzymes in rat and human salivary glands,” Histochemistry and Cell Biology, vol. 135, no. 4, pp. 389–396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Pongsa-Asawapaiboon, P. Asavaritikrai, B. Withyachumnarnkul, and A. Sumridthong, “Melatonin increases nerve growth factor in mouse submandibular gland,” Journal of Pineal Research, vol. 24, no. 2, pp. 73–77, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. J. C. Mayo, R. M. Sainz, D. X. Tan, I. Antolín, C. Rodríguez, and R. J. Reiter, “Melatonin and Parkinson's disease,” Endocrine, vol. 27, no. 2, pp. 169–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. A. Pappalla, R. J. Reiter, T. K. Bryant-Thomas, and B. Beggeler, “Oxidative mediated neurodegeneration in Alzheimer's diseases: melatonin and related antioxidant as neuroprotective agents,” Current Medicinal Chemistry, vol. 3, no. 1, pp. 233–243, 2003. View at Google Scholar
  53. V. Srinivasan, S. R. Pandi-Perumal, D. P. Cardinali, B. Poeggeler, and R. Hardeland, “Melatonin in Alzheimer's disease and other neurodegenerative disorders,” Behavioral and Brain Functions, vol. 2, p. 15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. C. Mayo, R. M. Sainz, D. X. Tan et al., “Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages,” Journal of Neuroimmunology, vol. 165, no. 1-2, pp. 139–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. S. C. Miller, P. S. R. Pandi, A. I. Esquifino, D. P. Cardinali, and G. J. M. Maestroni, “The role of melatonin in immuno-enhancement: potential application in cancer,” International Journal of Experimental Pathology, vol. 87, no. 2, pp. 81–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. R. J. Reiter, D. X. Tan, and M. A. Pappolla, “Melatonin relieves the neural oxidative burden that contributes to dementias,” Annals of the New York Academy of Sciences, vol. 1035, pp. 179–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Lissoni, “Is there a role for melatonin in supportive care?” Supportive Care in Cancer, vol. 10, no. 2, pp. 110–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. G. García-Santos, I. Antolín, F. Herrera et al., “Melatonin induces apoptosis in human neuroblastoma cancer cells,” Journal of Pineal Research, vol. 41, no. 2, pp. 130–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Martin, F. Herrera, and P. Carrera-Gonzalez, “Intra cellular signalling pathways involved in the cell growth inhibition of glioma cells by melatonin,” Cancer Research, vol. 66, no. 2, pp. 1081–1088, 2006. View at Publisher · View at Google Scholar
  60. S. J. Konturek, O. Zayachkivska, X. O. Havryluk et al., “Protective influence of melatonin against acute oesophageal lesions involves prostaglandins, nitric oxide and sensory nerves,” Journal of Physiology and Pharmacology, vol. 58, no. 2, pp. 361–377, 2007. View at Google Scholar
  61. H. Ç. Aras and J. Ekström, “Melatonin-evoked in vivo secretion of protein and amylase from the parotid gland of the anaesthetised rat,” Journal of Pineal Research, vol. 45, no. 4, pp. 413–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. J. C. Mechin and C. Toury, “Action of cariogenic diet on fixation and retention of skeleton and teeth strontium in rats,” Revue d"odonto-stomatologie, vol. 20, no. 1, pp. 55–59, 1973. View at Google Scholar · View at Scopus
  63. J. Waterhouse, T. Reilly, and G. Atkinson, “Jet-lag,” The Lancet, vol. 350, no. 9091, pp. 1611–1616, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. Petercop, “Melatonin, a novel oral sedative for dentistry,” Clinical Ontario Dentist, pp. 22–25, 2010. View at Google Scholar
  65. C. M. Forrest, G. M. Mackay, N. Stoy, T. W. Stone, and L. G. Darlington, “Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin,” British Journal of Clinical Pharmacology, vol. 64, no. 4, pp. 517–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Kedziora kornatowska, K. Szwczyk-Golec, J. Czuczejko, H. Pawluk, and K. Van Marke de Lumen, “Antioxidative affects of melatonin administration in elderly primary essential hypertension patients,” Journal of Pineal Research, vol. 45, pp. 312–317, 2008. View at Google Scholar
  67. K. Kdziora-Kornatowska, K. Szewczyk-Golec, M. Kozakiewicz et al., “Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients,” Journal of Pineal Research, vol. 46, no. 3, pp. 333–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Tamura, A. Takasaki, I. Miwa et al., “Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate,” Journal of Pineal Research, vol. 44, no. 3, pp. 280–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Srinivasan, D. W. Spence, A. Moscovitch et al., “Malaria: therapeutic implications of melatonin,” Journal of Pineal Research, vol. 48, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. O. D. S. Nunes and R. D. S. Pereira, “Regression of herpes viral infection symptoms using melatonin and SB-73: comparison with acyclovir,” Journal of Pineal Research, vol. 44, no. 4, pp. 373–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. M. P. Terron, J. Cubero, C. Barriga, E. Ortega, and A.B. Rodriguez, “Phagocytosis of Candida albicans and superoxide anion levels in ring dove (Streptopelia risoria) heterophils: effect of melatonin,” Journal of Neuroendocrinology, vol. 15, no. 12, pp. 1111–1115, 2003. View at Publisher · View at Google Scholar
  72. D. E. Blask, S. Cos, S. M. Hill, D. M. Burns, A. Lemus-Wilson, and D. S. Grosso, “Melatonin action on oncogenesis,” in Role of Melatonin and Pineal Peptides in Neuroimmunomodulation, R. J. Franschini and F. Reiter, Eds., pp. 233–240, Plenum, New York, NY, USA, 1991. View at Google Scholar
  73. H. Bartsch and C. Bartsch, “Effect of melatonin on experimental tumors under different photoperiods and times of administration,” Journal of Neural Transmission, vol. 52, no. 4, pp. 269–279, 1981. View at Google Scholar · View at Scopus
  74. J. S. Carman, R. M. Post, R. Buswell, and F. K. Goodwin, “Negative effects of melatonin on depression,” American Journal of Psychiatry, vol. 133, no. 10, pp. 1181–1186, 1976. View at Google Scholar · View at Scopus
  75. N. E. Rosenthal, D. A. Sack, and S. P. James, “Seasonal affective disorder and phototherapy,” Annals of the New York Academy of Sciences, vol. 453, pp. 260–269, 1985. View at Google Scholar · View at Scopus
  76. J. Beck-Friis, B.F. Kjellman, and B. Aperia, “Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome,” Acta Psychiatrica Scandinavica, vol. 71, no. 4, pp. 319–330, 1985. View at Google Scholar
  77. A. F. Wiechmann and W. K. O'Steen, “Melatonin increases photoreceptor susceptibility to light-induced damage,” Investigative Ophthalmology and Visual Science, vol. 33, no. 6, pp. 1894–1902, 1992. View at Google Scholar · View at Scopus
  78. A. Tailleux, G. Torpier, D. Bonnefont-Rousselot et al., “Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta,” Biochemical and Biophysical Research Communications, vol. 293, no. 3, pp. 1114–1123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Mattsson, I. Hannsson, and R. Holmdahl, “Pineal gland in autoimmunity: melatonin dependent exacerbation of collagen induced arthritis in mice,” Autoimmunity, vol. 17, no. 1, pp. 83–86, 1994. View at Publisher · View at Google Scholar
  80. K. Ganguly, P. Kundu, A. Banerjee, R. J. Reiter, and S. Swarnakar, “Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants,” Free Radical Biology and Medicine, vol. 41, no. 6, pp. 911–925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. R. J. Reiter, D. Melchiorri, E. Sewerynek et al., “A review of the evidence supporting melatonin's role as an antioxidant,” Journal of Pineal Research, vol. 18, no. 1, pp. 1–11, 1995. View at Google Scholar · View at Scopus
  82. D. X. Tan, L. C. Manchester, R. J. Reiter et al., “Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation,” Free Radical Biology and Medicine, vol. 29, no. 11, pp. 1177–1185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. C. M. Cagnoli, C. Atabay, E. Kharlamova, and H. Manev, “Melatonin protects neurons from singlet oxygen-induced apoptosis,” Journal of pineal research, vol. 18, no. 4, pp. 222–226, 1995. View at Google Scholar · View at Scopus
  84. D. Bongiorno, L. Ceraulo, M. Ferrugia, F. Filizzola, A. Ruggirello, and V. T. Liveri, “Localization and interactions of melatonin in dry cholesterol/lecithin mixed reversed micelles used as cell membrane models,” Journal of Pineal Research, vol. 38, no. 4, pp. 292–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Aydogan, M. Betul Yerer, and A. Goktas, “Melatonin and nitric oxide,” Journal of Endocrinological Investigation, vol. 29, no. 3, pp. 281–287, 2006. View at Google Scholar · View at Scopus
  86. I. Antolín, C. Rodriguez, R. M. Sáinz et al., “Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes,” FASEB Journal, vol. 10, no. 8, pp. 882–890, 1996. View at Google Scholar · View at Scopus
  87. C. Rodriguez, J. C. Mayo, R. M. Sainz et al., “Regulation of antioxidant enzymes: a significant role for melatonin,” Journal of Pineal Research, vol. 36, no. 1, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Tomás-Zapico and A. Coto-Montes, “A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes,” Journal of Pineal Research, vol. 39, no. 2, pp. 99–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. N. de la Rocha, A. Rotelli, C. F. Aguilar, and L. Pelzer, “Structural basis of the anti-inflammatory activity of melatonin,” Arzneimittel-Forschung/Drug Research, vol. 57, no. 12, pp. 782–786, 2007. View at Google Scholar · View at Scopus
  90. J. M. Guerrero, D. Pozo, S. García-Mauriño, C. Osuna, P. Molinero, and J. R. Calvo, “Involvement of nuclear receptors in the enhanced IL-2 production by melatonin in Jurkat cells,” Annals of the New York Academy of Sciences, vol. 917, pp. 397–403, 2000. View at Google Scholar · View at Scopus
  91. S. Garcia-Mauriño, M. G. Gonzalez-Haba, J. R. Calvo et al., “Melatonin enhances IL-2, IL-6, and IFN-γ production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes,” Journal of Immunology, vol. 159, no. 2, pp. 574–581, 1997. View at Google Scholar · View at Scopus
  92. S. Garcia-Maurino, D. Pozo, J. R. Calvo, and J. M. Guerrero, “Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines,” Journal of Pineal Research, vol. 29, no. 3, pp. 129–137, 2000. View at Google Scholar · View at Scopus
  93. A. Cutando, C. Arana, G. Gomez-Moreno et al., “Melatonin plasma and salivary and lymphocyte subpopulation in periodontal patients,” Special Care Dentistry, vol. 24, p. 169, 2004. View at Google Scholar
  94. P. J. Lardone, A. Carrillo-Vico, M. C. Naranjo et al., “Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production,” Journal of Cellular Physiology, vol. 206, no. 1, pp. 273–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. R. J. Reiter, D. X. Tan, A. Korkmaz et al., “Light at night, chronodisruption, melatonin suppression, and cancer risk: a review,” Critical Reviews in Oncogenesis, vol. 13, no. 4, pp. 303–328, 2007. View at Google Scholar · View at Scopus
  96. R. J. Reiter, “Mechanisms of cancer inhibition by melatonin,” Journal of Pineal Research, vol. 37, no. 3, pp. 213–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. M. P. Terron, J. Cubero, J. M. Marchena, C. Barriga, and A. Rodriguez, “Melatonin and aging: invitro effect of young and mature ring dove physiological concentrations of melatonin on the phagocytic functions of neutrophils from old ring dove,” Experimental Gerontology, vol. 37, no. 2-3, pp. 421–426, 2002. View at Publisher · View at Google Scholar
  98. M. P. Terron, S. P. Parades, C. Barriga, E. Ortega, and A. B. Rodriguez, “Comparitive study of heterophil phagocytic function in young and old ring doves (Streptopelia risona) and its relationship with melatonin levels,” Journal of Comparative Physiology B, vol. 174, no. 5, pp. 421–427, 2004. View at Google Scholar
  99. J. A. Roth, B. G. Kim, W. L. Lin, and M. I. Cho, “Melatonin promotes osteoblast differentiation and bone formation,” Journal of Biological Chemistry, vol. 274, no. 31, pp. 22041–22047, 1999. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Yasuda, “Bone and bone related biochemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligand (RANKL),” Clinical Calcium, vol. 16, no. 6, pp. 80–86, 2006. View at Google Scholar · View at Scopus
  101. B. F. Boyce, E. M. Schwarz, and L. Xing, “Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease,” Current Opinion in Rheumatology, vol. 18, no. 4, pp. 427–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. E.-Y. Choi, J.-Y. Jin, J.-Y. Lee, J.-I. Choi, I. S. Choi, and S. J. Kim, “Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity,” Journal of Pineal Research, vol. 50, no. 2, pp. 197–206, 2011. View at Google Scholar